| Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ... The Lancet Neurology 9 (1), 77-93, 2010 | 2413 | 2010 |
| Myostatin mutation associated with gross muscle hypertrophy in a child M Schuelke, KR Wagner, LE Stolz, C Hübner, T Riebel, W Kömen, ... New England Journal of Medicine 350 (26), 2682-2688, 2004 | 1880 | 2004 |
| Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care K Bushby, R Finkel, DJ Birnkrant, LE Case, PR Clemens, L Cripe, A Kaul, ... The Lancet Neurology 9 (2), 177-189, 2010 | 1390 | 2010 |
| Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management DJ Birnkrant, K Bushby, CM Bann, SD Apkon, A Blackwell, D Brumbaugh, ... The Lancet Neurology 17 (3), 251-267, 2018 | 1097 | 2018 |
| A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy KR Wagner, JL Fleckenstein, AA Amato, RJ Barohn, K Bushby, ... Annals of neurology 63 (5), 561-571, 2008 | 611 | 2008 |
| Loss of myostatin attenuates severity of muscular dystrophy in mdx mice KR Wagner, AC McPherron, N Winik, SJ Lee Annals of Neurology: Official Journal of the American Neurological …, 2002 | 575 | 2002 |
| Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells K Sadtler, K Estrellas, BW Allen, MT Wolf, H Fan, AJ Tam, CH Patel, ... Science 352 (6283), 366-370, 2016 | 532 | 2016 |
| Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction TA of the Safety The Lancet 358 (9282), 605-613, 2001 | 400 | 2001 |
| Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations KR Wagner, S Hamed, DW Hadley, AL Gropman, AH Burstein, ... Annals of Neurology: Official Journal of the American Neurological …, 2001 | 367 | 2001 |
| Telomere position effect: regulation of gene expression iwth progressive telomere shortening over long distances. WWE Robin J D, Ludlow A T, Batten K, Magdinier F, Stadler G, Wagner K R ... Genes Dev 28 (22), 2464-2476, 2014 | 323 | 2014 |
| Muscle regeneration in the prolonged absence of myostatin KR Wagner, X Liu, X Chang, RE Allen Proceedings of the national academy of sciences 102 (7), 2519-2524, 2005 | 319 | 2005 |
| Myostatin directly regulates skeletal muscle fibrosis ZB Li, HD Kollias, KR Wagner Journal of Biological Chemistry 283 (28), 19371-19378, 2008 | 306 | 2008 |
| Contemporary cardiac issues in Duchenne muscular dystrophy EM McNally, JR Kaltman, DW Benson, CE Canter, LH Cripe, D Duan, ... Circulation 131 (18), 1590-1598, 2015 | 288 | 2015 |
| Current treatment of adult Duchenne muscular dystrophy KR Wagner, N Lechtzin, DP Judge Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1772 (2), 229-237, 2007 | 212 | 2007 |
| The 87K postsynaptic membrane protein from Torpedo is a protein-tyrosine kinase substrate homologous to dystrophin KR Wagner, JB Cohen, RL Huganir Neuron 10 (3), 511-522, 1993 | 197 | 1993 |
| Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis TI Jones, JCJ Chen, F Rahimov, S Homma, P Arashiro, ML Beermann, ... Human molecular genetics 21 (20), 4419-4430, 2012 | 189 | 2012 |
| Concordant but varied phenotypes among Duchenne muscular dystrophy patient-specific myoblasts derived using a human iPSC-based model IY Choi, HT Lim, K Estrellas, J Mula, TV Cohen, Y Zhang, CJ Donnelly, ... Cell reports 15 (10), 2301-2312, 2016 | 164 | 2016 |
| A randomized, pilot trial of etanercept in dermatomyositis Muscle Study Group Ann Neurol, 2011 | 158 | 2011 |
| In vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy SR Choudhury, Z Fitzpatrick, AF Harris, SA Maitland, JS Ferreira, Y Zhang, ... Molecular Therapy 24 (7), 1247-1257, 2016 | 130 | 2016 |
| Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study KR Wagner, WH Giles, CJ Johnson, CY Ou, PF Bray, ... Stroke 29 (3), 581-585, 1998 | 129 | 1998 |
